Clinical Trials Directory

Trials / Unknown

UnknownNCT06031090

Clonidine Versus Granisetron for Shivering Prevension

Intravenous Clonidine Versus Granisetron for Prevention of Post Spinal Anesthesia Shivering in Cesarean Section

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
186 (estimated)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Prevention of post spinal anesthesia shivering during cesarean section with its associated discomfort, distress, aggravation of pain, increased metabolic demands, and increased oxygen consumption

Detailed description

Shivering is one of the most important periperative complications seen in clinical practice. Several mechanisms have been postulated for its pathogenesis. Anesthetic-induced inhibition of thermoregulation resulting in hypothermia is an important cause of post anesthesia shivering, uncontrolled spinal reflexes, and cutaneous vasodilation are the other suggested mechanisms involved in the pathogenesis of shivering. Opioid receptors, α2 receptors, and serotonergic receptors also are involved of shivering. Various drugs were studied for their potential role in prevention of peri-operative shivering such as tramadol, dexmedetomidine, ondansetron, ketamine, and pethidine. We decided to perform a well-designed study to compare clonidine and granisetron which has been recently introduced as drugs for prevention and control of shivering after spinal anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGClonidine Injectionintravenous Clonidine 0.5 µg/kg diluted in 10ml normal saline 20 minutes before spinal anesthesia
DRUGGranisetron Injectionintravenous 1mg of granisetron diluted in 10ml normal saline 20 minutes before spinal anesthesia.
DRUGNormal Saline 10 mL Injectionintravenous 10 ml normal saline 20 minutes before spinal anesthesia

Timeline

Start date
2023-03-05
Primary completion
2023-10-05
Completion
2023-10-30
First posted
2023-09-11
Last updated
2023-09-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06031090. Inclusion in this directory is not an endorsement.